Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Clinical relevance of St. John's wort drug interactions revisited
Simon Nicolussi, Jürgen Drewe, Veronika Butterweck, et al.
British Journal of Pharmacology (2019) Vol. 177, Iss. 6, pp. 1212-1226
Open Access | Times Cited: 114

Showing 1-25 of 114 citing articles:

Depression and Its Phytopharmacotherapy—A Narrative Review
Łukasz Dobrek, Krystyna Głowacka
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 5, pp. 4772-4772
Open Access | Times Cited: 58
Exploring the Safety, Efficacy, and Bioactivity of Herbal Medicines: Bridging Traditional Wisdom and Modern Science in Healthcare
Acharya Balkrishna, Nidhi Sharma, Deepika Srivastava, et al.
Future Integrative Medicine (2024) Vol. 3, Iss. 1, pp. 35-49
Open Access | Times Cited: 23
Depression and Anxiety Disorders
Oğuz Karamustafalıoğlu, Hüseyin Yumrukçal
(2025), pp. 335-476
Closed Access | Times Cited: 7
In Silico Repurposed Drugs against Monkeypox Virus
Hilbert Yuen In Lam, Jia Sheng Guan, Yuguang Mu
Molecules (2022) Vol. 27, Iss. 16, pp. 5277-5277
Open Access | Times Cited: 63
Future directions for the discovery of natural product-derived immunomodulating drugs: an IUPHAR positional review
Cherry L. Wainwright, Mauro Martins Teixeira, David L. Adelson, et al.
Pharmacological Research (2022) Vol. 177, pp. 106076-106076
Open Access | Times Cited: 53
Interactions between natural products and cancer treatments: underlying mechanisms and clinical importance
Wai-Jo Jocelin Chan, Jeffry Adiwidjaja, Andrew J. McLachlan, et al.
Cancer Chemotherapy and Pharmacology (2023) Vol. 91, Iss. 2, pp. 103-119
Open Access | Times Cited: 31
Current state of research on the clinical benefits of herbal medicines for non-life-threatening ailments
Sandra Salm, Jochen Rutz, Marjan van den Akker, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 25
Synergy, Additive Effects, and Antagonism of Drugs with Plant Bioactive Compounds
Noureddine Chaachouay
Drugs and Drug Candidates (2025) Vol. 4, Iss. 1, pp. 4-4
Open Access | Times Cited: 1
Natural drug delivery systems for the treatment of neurodegenerative diseases
Greta Kaspute, Arūnas Ramanavičius, Urtė Prentice
Molecular Biology Reports (2025) Vol. 52, Iss. 1
Closed Access | Times Cited: 1
The role of toxicology in climate change: Understanding the risks of novel environmental toxins
Esther Ugo Alum
Sustainable Environment (2025) Vol. 11, Iss. 1
Open Access | Times Cited: 1
Pharmacokinetic Interactions between Herbal Medicines and Drugs: Their Mechanisms and Clinical Relevance
Laura Rombolà, Damiana Scuteri, Marilisa Straface, et al.
Life (2020) Vol. 10, Iss. 7, pp. 106-106
Open Access | Times Cited: 69
Unpredictable adverse effects of herbal products
Nurşen Başaran, Duygu Paslı, Arif Ahmet Başaran
Food and Chemical Toxicology (2021) Vol. 159, pp. 112762-112762
Closed Access | Times Cited: 47
Optimization of ultrasonic-assisted polysaccharide extraction from Hyperici Perforati Herba using response surface methodology and assessment of its antioxidant activity
Jiayu Gao, Dongyi Hu, Yang Shen, et al.
International Journal of Biological Macromolecules (2022) Vol. 225, pp. 255-265
Closed Access | Times Cited: 38
Knowledge and Beliefs about Herb/Supplement Consumption and Herb/Supplement–Drug Interactions among the General Population, including Healthcare Professionals and Pharmacists: A Systematic Review and Guidelines for a Smart Decision System
Artemisa R. Dores, Miguel Peixoto, Maria Castro, et al.
Nutrients (2023) Vol. 15, Iss. 10, pp. 2298-2298
Open Access | Times Cited: 22
Herb-Drug Interactions and Their Impact on Pharmacokinetics: An Update
Wenhao Cheng, Kexin Xia, Siyang Wu, et al.
Current Drug Metabolism (2023) Vol. 24, Iss. 1, pp. 28-69
Closed Access | Times Cited: 18
Climate change and its impact on the bioactive compound profile of medicinal plants: implications for global health
Esther Ugo Alum
Plant Signaling & Behavior (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 8
Nonadherence in Hypertension: How to Develop and Implement Chemical Adherence Testing
Dan Lane, Alexander J. Lawson, Angela Burns, et al.
Hypertension (2021) Vol. 79, Iss. 1, pp. 12-23
Open Access | Times Cited: 34
Complementary and Alternative Medicines in the Management of Heart Failure: A Scientific Statement From the American Heart Association
Sheryl L. Chow, Biykem Bozkurt, William L. Baker, et al.
Circulation (2022) Vol. 147, Iss. 2
Open Access | Times Cited: 26
Phytotherapy of mood disorders in the light of microbiota-gut-brain axis.
Maciej Korczak, Maciej Pilecki, Sebastian Granica, et al.
Phytomedicine (2023) Vol. 111, pp. 154642-154642
Closed Access | Times Cited: 13
Mechanisms of hepatocellular toxicity associated with the components of St. John’s Wort extract hypericin and hyperforin in HepG2 and HepaRG cells
Vanessa Fabienne Abegg, Miljenko V. Panajatovic, Riccardo Vincenzo Mancuso, et al.
Toxicology Letters (2024) Vol. 393, pp. 1-13
Open Access | Times Cited: 5
Herbal medicines for the treatment of cardiovascular diseases: Benefits and risks – A narrative review
Lucinda Villaescusa, Cristina Zaragozá, Francisco Torrens Zaragozá, et al.
International Journal of Cardiology (2023) Vol. 385, pp. 44-52
Closed Access | Times Cited: 12
Pharmacokinetic and pharmacodynamic herb-drug interactions—part I. Herbal medicines of the central nervous system
Szilvia Czigle, Milan Nagy, Přemysl Mladěnka, et al.
PeerJ (2023) Vol. 11, pp. e16149-e16149
Open Access | Times Cited: 11
St. John's wort extract with a high hyperforin content does not induce P‐glycoprotein activity at the human blood–brain barrier
Myriam El Biali, Michael Wölfl‐Duchek, Matthias Jackwerth, et al.
Clinical and Translational Science (2024) Vol. 17, Iss. 5
Open Access | Times Cited: 4
Managing novel therapies and concomitant medications in chronic lymphocytic leukemia: key challenges
Sofija Kozarac, Jelena Ivanović, Milena Mitrović, et al.
Frontiers in Pharmacology (2025) Vol. 15
Open Access
Page 1 - Next Page

Scroll to top